Genome-wide linkage analysis for identifying quantitative trait loci involved in the regulation of lipoprotein a (Lpa) levels

European Journal of Human Genetics

Volumn 16, Issue 11, 2008, Pages 1372-1379

  López, Sonia ^a   Buil, Alfonso ^a   Ordoñez, Jordi ^a,b   Souto, Juan Carlos ^a   Almasy, Laura ^c   Lathrop, Mark ^d   Blangero, John ^c   Blanco Vaca, Francisco ^a,b,e   Fontcuberta, Jordi ^a   Soria, José Manuel ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^d CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; GENOMIC DNA; LIPOPROTEIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHILD; CHROMOSOME 2; CHROMOSOME 6; FEMALE; GENE IDENTIFICATION; GENE LOCATION; GENE MAPPING; GENE STRUCTURE; GENETIC CORRELATION; GENETIC REGULATION; GENETIC SCREENING; GENOME ANALYSIS; GENOTYPE; HUMAN; LINKAGE ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; THROMBOPHILIA;

ADOLESCENT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; HUMANS; LIPOPROTEIN(A); LIPOPROTEINS; LOD SCORE; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RISK FACTORS; SPAIN; THROMBOPHILIA; YOUNG ADULT;

EID: 54549096882     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2008.114     Document Type: Article

References (33)

1. Marcovina SM, Koschinsky ML: Lipoprotein(a) as a risk factor for coronary artery disease. Am J Cardiol 1998; 82: 57U-66U.
2. Danesh J, Collins R, Peto R: Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000; 102: 1082-1085.
3. Koschinsky ML: Novel insights into Lp(a) physiology and pathogenicity: more questions than answers? Cardiovasc Hematol Disord Drug Targets 2006; 6: 267-278.
4. Berglund LA Ramakrishnan R: Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol 2004; 24: 2219-2226.
5. Boerwinkle E, Menzel HJ, Kraft HG, Utermann G: Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet 1989; 82: 73-78.
6. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH: Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90 52-60.
7. Paultre F, Pearson TA, Weil HF et al: High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler Thromb Vasc Biol 2000; 20: 2619-2624.
8. Tsimikas S, Tsironis LD, Tselepis AD: New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. Arterioscler Thromb Vasc Biol 2007 and N Engl J Med 2005; 353: 46-57.
9. Luke MM, Kane JP, Liu DM et al: A polymorphism in the proteaselike domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler Thromb Vasc Biol 2007; 27: 2030-2036.
10. Chretien JP, Coresh J, Berthier-Schaad Y et al: Three single- nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans. J Med Genet 2006; 43: 917-923.
11. Ogorelkova M, Kraft HG, Ehnholm C, Utermann G: Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6-10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians. Hum Mol Genet 2001; 10: 815-824.
12. Parson W, Kraft HG, Niederstatter H et al: A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a). Hum Mutat 2004; 24: 474-480.
13. Barlera S, Specchia C, Farrall M et al: Multiple QTL influence the serum Lp(a) concentration: A genome-wide linkage screen in the PROCARDIS study. Eur J Hum Genet 2007; 15: 221-227.
14. Broeckel U, Hengstenberg C, Mayer B et al: A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002; 30: 210-214.
15. Barkley RA, Brown AC, Hanis CL, Kardia SL, Turner ST, Boerwinkle E: Lack of genetic linkage evidence for a trans-acting factor having a large effect on plasma lipoprotein[a] levels in African Americans. J Lipid Res 2003; 44: 1301-1305.
16. Souto JC, Almasy L, Borrell M et al: Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 2000; 101: 1546-1551.
17. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
18. Soria JM, Almasy L, Souto JC et al: A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease. Am J Hum Genet 2002; 70 567-574.
19. Dyke A: PEDSYS: a pedigree data management sytem. User's manual. Tech. Rep. No. 2 San Antonio, Texas: Southwest Foundation for Biomedical Research, 1995.
20. Almasy L, Blangero J: Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198-1211.
21. Allison DB, Neale MC, Zannolli R, Schork NJ, Amos CI, Blangero J: Testing the robustness of the likelihood-ratio test in a variance- component quantitative-trait loci-mapping procedure. Am J Hum Genet 1999; 65: 531-544.
22. Blangero J, Williams JT, Almasy L: Robust LOD scores for variance component-based linkage analysis. Genet Epidemiol 2000; 19: S8-14.
23. Hopper JL, Mathews JD: Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet 1982; 46: 373-383.
24. Boehnke M, Lange K: Ascertainment and goodness of fit of variance component models for pedigree data. Prog Clin Biol Res 1984; 147: 173-192.
25. Feingold E, Brown PO, Siegmund D: Gaussian models for genetic linkage analysis using complete high-resolution maps of identity by descent. Am J Hum Genet 1993; 53: 234-251.
26. Mitchell BD, Kammerer CM, Blangero J et al: Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 1996; 94: 2159-2170.
27. Ober C, Abney M, McPeek MS: The genetic dissection of complex traits in a founder population. Am J Hum Genet 2001; 69: 1068-1079.
28. Austin MA, Sandholzer C, Selby JV, Newman B, Krauss RM, Utermann G: Lipoprotein(a) in women twins: Heritability and relationship to apolipoprotein(a) phenotypes. Am J Hum Genet 1992; 51: 829-840.
29. Beekman M, Heijmans BT, Martin NG et al: Two-locus linkage analysis applied to putative quantitative trait loci for lipoprotein(a) levels. Twin Res 2003; 6: 322-324.
30. Caplice NM, Panetta C, Peterson TE et al: Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: A novel link between lipoproteins and thrombosis. Blood 2001; 98: 2980-2987.
31. Olkkonen VM, Lehto M: Oxysterols and Rxysterol binding proteins: role in lipid metabolism and atherosclerosis. Ann Med 2004; 36: 562-572.
32. Adam-Vizi V, Chinopoulos C: Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci 2006; 27: 639-645.
33. Kundu TK, Hille R, Velayutham M, Zweier JL: Characterization of superoxide production from aldehyde oxidase: An important source of oxidants in biological tissues. Arch Biochem Biophys 2007; 460 113-121.